| 2008 |
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. |
PloS one |
312 |
18612426 |
| 1991 |
Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. |
The Journal of experimental medicine |
187 |
1940798 |
| 2001 |
P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. |
The EMBO journal |
176 |
11483501 |
| 1997 |
A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. |
Infection and immunity |
146 |
9038325 |
| 2007 |
Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies. |
Parasitology |
104 |
17714601 |
| 1998 |
Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. |
Molecular medicine (Cambridge, Mass.) |
98 |
9990863 |
| 2000 |
Distinct roles for pbs21 and pbs25 in the in vitro ookinete to oocyst transformation of Plasmodium berghei. |
Journal of cell science |
72 |
10984433 |
| 2013 |
Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. |
Applied and environmental microbiology |
71 |
23603678 |
| 2016 |
Genome-scale comparison of expanded gene families in Plasmodium ovale wallikeri and Plasmodium ovale curtisi with Plasmodium malariae and with other Plasmodium species. |
International journal for parasitology |
67 |
27392654 |
| 2007 |
Mosquito stage, transmission blocking vaccines for malaria. |
Current opinion in infectious diseases |
63 |
17762780 |
| 2017 |
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25. |
Nature communications |
58 |
29146922 |
| 2005 |
The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms. |
Nature structural & molecular biology |
58 |
16327807 |
| 2001 |
Anopheles gambiae laminin interacts with the P25 surface protein of Plasmodium berghei ookinetes. |
Molecular and biochemical parasitology |
56 |
11223130 |
| 2017 |
Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate. |
Scientific reports |
51 |
28091576 |
| 2011 |
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. |
PloS one |
49 |
22216279 |
| 2006 |
The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials. |
Vaccine |
47 |
17049690 |
| 1997 |
Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. |
Infection and immunity |
47 |
9169761 |
| 2010 |
Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. |
Vaccine |
46 |
20637303 |
| 2000 |
Characterisation and expression of pbs25, a sexual and sporogonic stage specific protein of Plasmodium berghei. |
Molecular and biochemical parasitology |
46 |
10989152 |
| 2001 |
Cryofracture electron microscopy of the ookinete pellicle of Plasmodium gallinaceum reveals the existence of novel pores in the alveolar membranes. |
Journal of structural biology |
45 |
11562165 |
| 2005 |
Overexpression and altered nucleocytoplasmic distribution of Anopheles ovalbumin-like SRPN10 serpins in Plasmodium-infected midgut cells. |
Cellular microbiology |
44 |
15659062 |
| 2014 |
Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
Infection and immunity |
37 |
25092912 |
| 2007 |
Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines. |
Eukaryotic cell |
37 |
17557884 |
| 2005 |
Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells? |
Malaria journal |
34 |
15733320 |
| 2019 |
A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies. |
Frontiers in immunology |
29 |
31681301 |
| 2019 |
Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming. |
Frontiers in immunology |
27 |
31024558 |
| 2007 |
The surface protein Pvs25 of Plasmodium vivax ookinetes interacts with calreticulin on the midgut apical surface of the malaria vector Anopheles albimanus. |
Molecular and biochemical parasitology |
24 |
17442413 |
| 2016 |
Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax. |
Vaccine |
23 |
27177945 |
| 2019 |
A Multi-Stage Plasmodium vivax Malaria Vaccine Candidate Able to Induce Long-Lived Antibody Responses Against Blood Stage Parasites and Robust Transmission-Blocking Activity. |
Frontiers in cellular and infection microbiology |
19 |
31119106 |
| 2006 |
3' gene regulatory elements required for expression of the Plasmodiumfalciparum developmental protein, Pfs25. |
Molecular and biochemical parasitology |
18 |
16439031 |
| 2017 |
Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India. |
Tropical medicine & international health : TM & IH |
14 |
29029367 |
| 2017 |
Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate. |
Analytical biochemistry |
10 |
29162427 |
| 2008 |
Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study. |
In silico biology |
10 |
19032156 |
| 2024 |
Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax. |
Vaccine |
7 |
39033079 |
| 2021 |
Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate. |
Parasites & vectors |
7 |
34749796 |
| 2018 |
Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity. |
Scientific reports |
6 |
29371619 |
| 2023 |
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles. |
NPJ vaccines |
5 |
37061547 |
| 2022 |
Sterile protection and transmission blockade by a multistage anti-malarial vaccine in the pre-clinical study. |
Frontiers in immunology |
5 |
36248835 |
| 2010 |
Plasmodium berghei ookinetes glide and release Pbs25 and circumsporozoite thrombospondin-related protein on solid surface substrata. |
The Journal of parasitology |
5 |
19747017 |
| 2011 |
Structure of Fab fragment of malaria transmission blocking antibody 2A8 against P. vivax P25 protein. |
International journal of biological macromolecules |
4 |
22037467 |
| 2024 |
A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study. |
Frontiers in immunology |
3 |
38745665 |
| 2008 |
A very large C-loop in EGF domain IV is characteristic of the P28 family of ookinete surface proteins. |
Journal of molecular modeling |
3 |
19057932 |